Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
M&A activity was also up in 2005 with 205 deals completed compared to the 159 deals in 2004. Large pharmaceutical and biotechnology companies acquired products, expertise, and interestingly vaccine development and production infrastructure.(00:56:09) The largest deals focused on marketed or late st...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
